Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 57.63 -0.02 (-0.03%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 ... 7 8 9 10 11 12 13 14 15 ... 30 31 Next > This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now September 14, 2023 This market is currently in its infancy. Via The Motley Fool 'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi September 14, 2023 First Wave BioPharma Inc (NASDAQ: FWBI) announced an agreement with Sanofi SA (NASDAQ: SNY) to license Capeserod, a selective 5-HT4 receptor partial agonist, which First Wave will repurpose and develop... Via Benzinga Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm September 13, 2023 Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony. Via InvestorPlace Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' September 13, 2023 Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. Via Investor's Business Daily (SNY) - Analyzing Sanofi's Short Interest August 29, 2023 Via Benzinga Could This Medicine Be the Next Winner for Novartis? August 23, 2023 The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials. Via The Motley Fool 2 Top Biotech Stocks to Buy Right Now August 14, 2023 These drugmakers are among the most dominant in the world. Via The Motley Fool Why Shares of MacroGenics Are Jumping Thursday August 10, 2023 The company announced second-quarter earnings. Via The Motley Fool Looking Into Sanofi's Recent Short Interest August 08, 2023 Via Benzinga FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth August 22, 2023 Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth... Via Benzinga Exposures Product Safety Is Regeneron Pharmaceuticals Still a Top Growth Stock? August 21, 2023 The biotech's focus on innovation could be a boon for shareholders. Via The Motley Fool 2 Biotech Stocks That Could Make You Richer August 18, 2023 Neither is performing particularly well this year compared to the broader market, but don't let that chase you away. Via The Motley Fool Amazon's Boon for Diabetes Patients - Streamlining Pharmacy Discounts August 15, 2023 Amazon.Com Inc's (NASDAQ: AMZN) online pharmacy launched a new initiativ Via Benzinga As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab? August 08, 2023 Tiziana Life Sciences, Inc. Via Benzinga The Top Healthcare Stocks to Buy With $100 July 30, 2023 There's no need to have a fortune to invest in stocks. Via The Motley Fool Sanofi (SNY) Q2 2023 Earnings Call Transcript July 28, 2023 SNY earnings call for the period ending June 30, 2023. Via The Motley Fool Sanofi's Earnings Outlook July 27, 2023 Via Benzinga Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon August 03, 2023 Tiziana Life Sciences (NASDAQ: TLSA), a clinical-stage biotechnology company focused on developing immunotherapies, will soon announce the 6-month results for patients with non-active Secondary... Via Benzinga Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist August 01, 2023 Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories July 28, 2023 Bloomberg Via Benzinga How Is The Market Feeling About Sanofi? July 20, 2023 Via Benzinga Sanofi Reports Lower Q2 Earnings, But Lifts 2023 Outlook On New Drug Launches July 28, 2023 Sanofi SA (NASDAQ: SNY) reported a 1% decline in Q2 business operating in Via Benzinga US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon July 28, 2023 Stocks appear to have shaken off Thursday's negativity and are positioned for a rebound on upbeat earnings. Via Benzinga Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session July 28, 2023 U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Exscientia is the Sniper of the AI Drug Discovery Industry July 27, 2023 News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Earnings Scheduled For July 28, 2023 July 28, 2023 Companies Reporting Before The Bell • Sanofi (NASDAQ:SNY) is likely to report quarterly earnings at $1.58 per share on revenue of $11.32 billion. Via Benzinga Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports July 26, 2023 The Medicines and Healthcare Products Regulatory Agency (MHRA), the U.K.'s drug regulatory authority, is reportedly scrutinizing a category of drugs used in diabetes medication and a weight loss... Via Benzinga 7 Blue-Chip Stocks That Are Screaming Buys Right Now: July 2023 July 23, 2023 Even some of the top players of the market don’t get the attention they deserve, making these blue-chip stocks compelling. Via InvestorPlace Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications July 20, 2023 From Recludix Pharma, Inc. Via GlobeNewswire NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories July 18, 2023 Wall Street Journal Via Benzinga < Previous 1 2 ... 7 8 9 10 11 12 13 14 15 ... 30 31 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.